29 Sept 20251cites
Efficacy and safety of Mirikizumab in the treatment of moderate to severe inflammatory bowel diseases: a systematic review and updated meta-analysisPublisher siteInflammopharmacology, Inflammatory Bowel Disease
Active, last published 2026
In liver disease diagnosis and treatment
Anifatou B.
Kortim
Scholar“Research focused on Liver Disease Diagnosis and Treatment and adjacent fields.”
University of Bamenda
Cameroon
Claim Your ProfileCameroon1
H-index
7
Citations
Anifatou has not officially claimed their profile. If you are Anifatou, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
nifatou B. Kortim is a researcher working on Liver Disease Diagnosis and Treatment. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Anifatou's work has been cited 7 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Liver Disease Diagnosis and Treatment×1
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Bamenda, CameroonDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
2 works1 Apr 2025Open access6cites
Efficacy, Safety, and Tolerability of Farnesoid X Receptor Agonists in the Treatment of Metabolic Dysfunction-associated Steatotic Liver Disease: A Systematic Review and Meta-analysisPublisher siteJournal of Clinical and Experimental Hepatology, Liver Disease Diagnosis and Treatment
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Anifatou?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you